Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eco Animal Health Group Plc | LSE:EAH | London | Ordinary Share | GB0032036807 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.50 | -2.86% | 119.00 | 118.00 | 120.00 | 122.50 | 118.00 | 122.50 | 23,190 | 14:47:33 |
Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
---|---|---|---|---|---|
Pharmaceuticals & Biotechnology | 105.6 | 20.3 | 12.1 | 9.9 | 80 |
Eco Animal Health Group PLC Director Dealings
30/11/2021 12:38pm
UK Regulatory (RNS & others)
TIDMEAH
RNS Number : 0588U
Eco Animal Health Group PLC
30 November 2021
30 November 2021
ECO Animal Health Group PLC
("ECO" or "the Company")
Directors Dealings
ECO Animal Health Group plc was notified today that on 30 November 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.
Marc Loomes, Chief Executive Officer of the Company, purchased 33,244 Ordinary Shares at a price of 150.40 pence per Ordinary Share. As a result of this transaction, Marc Loomes' total shareholding in the Company comprises 33,244 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital.
Christopher Wilks, Chief Financial Officer of the Company, purchased 16,595 Ordinary Shares at a price of 150.64 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 24,095 Ordinary Shares, representing approximately 0.04 per cent. of the Company's issued share capital.
Contacts:
ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO) 020 8447 6906 IFC Advisory Graham Herring Zach Cohen 020 3934 6630 Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas 020 7496 3000 Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden 020 7418 8900 Equity Development Hannah Crowe Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products
PDMR Notification
The notification below is made in accordance with the requirements of MAR
Acquisition of Ordinary Shares
1. Details of the person discharging managerial responsibilities / person closely associated a. Name Marc Loomes ======================== ========================================= 2. Reason for the notification =================================================================== a. Position/status Chief Executive Officer ======================== ========================================= b. Initial notification Initial notification /Amendment ======================== ========================================= 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor =================================================================== a. Name Eco Animal Health Group Plc ======================== ========================================= b. LEI 2138009XN9DJ3YP70B55 ======================== ========================================= 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted =================================================================== a. Description Ordinary shares of 5p each. of the Financial instrument, GB0032036807 type of instrument Identification code ======================== ========================================= b. Nature of the Acquisition of Ordinary Shares transaction ======================== ========================================= c. Price(s) and Price(s) Volume(s) volume(s) 150.40p 33,244 ======================== ========================================= d. Aggregated information Aggregated n/a volume Price ======================== ========================================= e. Date of the 30 November 2021 transaction ======================== ========================================= f. Place of the London Stock Exchange, AIM Market (XLON) transaction ======================== ========================================= 1. Details of the person discharging managerial responsibilities / person closely associated a. Name Christopher Wilks ======================== ========================================= 2. Reason for the notification =================================================================== a. Position/status Chief Financial Officer ======================== ========================================= b. Initial notification Initial notification /Amendment ======================== ========================================= 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor =================================================================== a. Name Eco Animal Health Group Plc ======================== ========================================= b. LEI 2138009XN9DJ3YP70B55 ======================== ========================================= 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted =================================================================== a. Description Ordinary shares of 5p each. of the Financial instrument, GB0032036807 type of instrument Identification code ======================== ========================================= b. Nature of the Acquisition of Ordinary Shares transaction ======================== ========================================= c. Price(s) and Price(s) Volume(s) volume(s) 150.64p 16,595 ======================== ========================================= d. Aggregated information Aggregated n/a volume Price ======================== ========================================= e. Date of the 30 November 2021 transaction ======================== ========================================= f. Place of the London Stock Exchange, AIM Market (XLON) transaction ======================== =========================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFZMFMZGKGMZM
(END) Dow Jones Newswires
November 30, 2021 07:38 ET (12:38 GMT)
1 Year Eco Animal Health Chart |
1 Month Eco Animal Health Chart |